USP6
Ubiquitin carboxyl-terminal hydrolase 6
Also known as: HRP1, Tre-2, TRE17, Tre2, TRESMCR, UBP6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35125
- Gene
- USP6
- Ensembl
- ENSG00000129204
- Chromosome
- 17
- Canonical length
- 1406 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Enables cysteine-type deubiquitinase activity. Involved in protein deubiquitination and regulation of postsynaptic neurotransmitter receptor internalization. Located in plasma membrane and recycling endosome. Is active in glutamatergic synapse and postsynaptic density, intracellular component. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1406 residues, UniProt reviewed canonical sequence.
>P35125|USP6
1 MDMVENADSL QAQERKDILM KYDKGHRAGL PEDKGPEPVG INSSIDRFGI LHETELPPVT
61 AREAKKIRRE MTRTSKWMEM LGEWETYKHS SKLIDRVYKG IPMNIRGPVW SVLLNIQEIK
121 LKNPGRYQIM KERGKRSSEH IHHIDLDVRT TLRNHVFFRD RYGAKQRELF YILLAYSEYN
181 PEVGYCRDLS HITALFLLYL PEEDAFWALV QLLASERHSL PGFHSPNGGT VQGLQDQQEH
241 VVPKSQPKTM WHQDKEGLCG QCASLGCLLR NLIDGISLGL TLRLWDVYLV EGEQVLMPIT
301 SIALKVQQKR LMKTSRCGLW ARLRNQFFDT WAMNDDTVLK HLRASTKKLT RKQGDLPPPA
361 KREQGSLAPR PVPASRGGKT LCKGYRQAPP GPPAQFQRPI CSASPPWASR FSTPCPGGAV
421 REDTYPVGTQ GVPSLALAQG GPQGSWRFLE WKSMPRLPTD LDIGGPWFPH YDFEWSCWVR
481 AISQEDQLAT CWQAEHCGEV HNKDMSWPEE MSFTANSSKI DRQKVPTEKG ATGLSNLGNT
541 CFMNSSIQCV SNTQPLTQYF ISGRHLYELN RTNPIGMKGH MAKCYGDLVQ ELWSGTQKSV
601 APLKLRRTIA KYAPKFDGFQ QQDSQELLAF LLDGLHEDLN RVHEKPYVEL KDSDGRPDWE
661 VAAEAWDNHL RRNRSIIVDL FHGQLRSQVK CKTCGHISVR FDPFNFLSLP LPMDSYMDLE
721 ITVIKLDGTT PVRYGLRLNM DEKYTGLKKQ LRDLCGLNSE QILLAEVHDS NIKNFPQDNQ
781 KVQLSVSGFL CAFEIPVPSS PISASSPTQI DFSSSPSTNG MFTLTTNGDL PKPIFIPNGM
841 PNTVVPCGTE KNFTNGMVNG HMPSLPDSPF TGYIIAVHRK MMRTELYFLS PQENRPSLFG
901 MPLIVPCTVH TRKKDLYDAV WIQVSWLARP LPPQEASIHA QDRDNCMGYQ YPFTLRVVQK
961 DGNSCAWCPQ YRFCRGCKID CGEDRAFIGN AYIAVDWHPT ALHLRYQTSQ ERVVDKHESV
1021 EQSRRAQAEP INLDSCLRAF TSEEELGESE MYYCSKCKTH CLATKKLDLW RLPPFLIIHL
1081 KRFQFVNDQW IKSQKIVRFL RESFDPSAFL VPRDPALCQH KPLTPQGDEL SKPRILAREV
1141 KKVDAQSSAG KEDMLLSKSP SSLSANISSS PKGSPSSSRK SGTSCPSSKN SSPNSSPRTL
1201 GRSKGRLRLP QIGSKNKPSS SKKNLDASKE NGAGQICELA DALSRGHMRG GSQPELVTPQ
1261 DHEVALANGF LYEHEACGNG CGDGYSNGQL GNHSEEDSTD DQREDTHIKP IYNLYAISCH
1321 SGILSGGHYI TYAKNPNCKW YCYNDSSCEE LHPDEIDTDS AYILFYEQQG IDYAQFLPKI
1381 DGKKMADTSS TDEDSESDYE KYSMLQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against USP6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 19 nTPM
- testis: 12 nTPM
- retina: 2.7 nTPM
- ovary: 2 nTPM
- choroid plexus: 1.3 nTPM
- cervix: 1 nTPM
Single-cell type
- myonuclei: 90 nCPM
- early primary spermatocytes: 65 nCPM
- early spermatids: 41 nCPM
- late spermatids: 29 nCPM
- undifferentiated spermatogonia: 23 nCPM
- differentiating spermatogonia: 19 nCPM
Immune cell
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 4.8 nTPM
- white matter: 3.8 nTPM
- medulla oblongata: 3.1 nTPM
- basal ganglia: 2.7 nTPM
- cerebral cortex: 2.7 nTPM
- cerebellum: 2.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.14
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- protein deubiquitination
- protein modification process
- proteolysis
- regulation of postsynaptic neurotransmitter receptor internalization
- regulation of vesicle-mediated transport
Molecular functions
- calmodulin binding
- cysteine-type deubiquitinase activity
- cysteine-type endopeptidase activity
- nucleic acid binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Rab-GAP-TBC domain
- Peptidase C19, ubiquitin carboxyl-terminal hydrolase
- Ubiquitin specific protease, conserved site
- Ubiquitin specific protease UPS, catalytic domain
- Rab-GAP-TBC domain superfamily
- Papain-like cysteine peptidase superfamily
- Ubiquitin carboxyl-terminal hydrolase
- Ubiquitin carboxyl-terminal hydrolase
- Rab-GTPase-TBC domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of USP6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads USP6 as an antibody target. Whether an autoantibody or antibody against USP6 could matter depends on whether native USP6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
USP6 is annotated at the cell surface, where native USP6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label USP6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...